ReviewInternational journal of molecular sciences2023

GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms.

Jay S SchneiderPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.